What is the Purpose of this Study?
This research will answer three key questions: (1) can TRE improve clinical outcomes, including treatment toxicity, patient-reported outcomes, and tumor regression (Aim 1) (2) do the underlying molecular mechanisms support the Differential Stress Sensitization theory (Aim 2) (3) how does TRE affect mood, social functioning and lifestyle behaviors to moderate patient outcomes (Aim 3).
Eligibility
- * Any sex/gender of any ethnic/racial background
- * Age greater than or equal to 18 years
- * Histologically confirmed rectal cancer stage II, III, or IV (if curative) per AJCC criteria
- * Histologically confirmed breast cancer stage II, III, or IV (only if definitive intent) per AJCC criteria
Where can I participate?
- CS Cancer at Beverly Hills
- CS Cancer at Cedars-Sinai Medical Center
- CS Cancer at The Angeles Clinic and Research Institute
- Hunt Cancer Institute, an Affiliate of Cedars-Sinai Cancer
- University of Alabama (Study Affiliate)
More about this Clinical Trial
What is the full name of this clinical trial?
IIT2020-26-FIGUEIREDO-TRE: Time-Restricted Eating and Cancer: Clinical Outcomes, Mechanisms, and Moderators